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Abstract This study defines a critical role for Btk in regulating TLR4-induced crosstalk be-
tween antigen presenting cells (APCs) and natural killer (NK) cells. Reduced levels of IL-12, IL-
18 and IFN-γ were observed in Btk-deficient mice and ex vivo generated macrophages and den-
dritic cells (DCs) following acute LPS administration, whilst enhanced IL-10 production was ob-
served. In addition, upregulation of activation markers and antigen presentation molecules on
APCs was also impaired in the absence of Btk. APCs, by virtue of their ability to produce IL-12
and IL-18, are strong inducers of NK-derived IFN-γ. Co-culture experiments demonstrate that
Btk-deficient DCs were unable to drive wild-type or Btk-deficient NK cells to induce IFN-γ pro-
duction, whereas these responses could be restored by exogenous administration of IL-12 and
IL-18. Thus Btk is a critical regulator of APC-induced NK cell activation by virtue of its ability
to regulate IL-12 and IL-18 production in response to acute LPS administration.
© 2011 Elsevier Inc. All rights reserved.
1. Introduction
During infection, myeloid cells play a key role not only as our
first line of defense but also as key cells that contribute to
the activation of other innate immune cells such as natural
killer (NK) cells. In this respect Toll-like receptor (TLR) stim-
ulation of antigen presenting cells (APCs) such as macro-
phages and dendritic cells, drives the production of the key
NK cell activating cytokines, IL-12 and IL-18, in addition to
enhancing cell–cell contact between APCs and NK which is
also known to be important in NK cell activation, interferon
(IFN)-γ production and acquisition of effector function [1-5].
Given the critical importance of IFN-γ in immune response to
pathogens, cross-talk between cells of the innate immune
system is critical for the effective clearance of pathogens,
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particularly intracellular bacterial and viral infections. The
pathways and proteins involved in the activation of TLRs
and subsequent production of inflammatory cytokines and
type I IFNs have been studied in great detail, however
there have been conflicting reports regarding the role of
Bruton's tyrosine kinase (Btk) in promoting Toll-like receptor
(TLR)-4 mediated immune responses in both cells of the in-
nate and adaptive immune response.
Btk is a non-receptor tyrosine kinase belonging to the
Tec family of kinases (TFKs), which includes Tec, Itk, Txk
and Bmx [6]. Btk has several structural domains, including
N-terminus, PH, Tec homology (TH), SH2, SH3, and kinase
(SH1) domains, that are important in interacting with a
range of proteins critical for intracellular signaling [6].
Btk inactivation or deficiency gives rise to an immune-
deficient condition known as X-linked agammaglobulinemia
(XLA), where B-cells fail to progress from pro-B cell to pre-
B cell in the bone marrow and subsequently these cells are
unable to produce immunoglobulins (Ig) or mature into an-
tibody secreting plasma cells [7]. Thus individuals with XLA
are unable to mount a humoral immune response and suf-
fer from recurrent bacterial and enteroviral infections [8],
with reports strongly indicating that defects in other cell
types may contribute to the poor immunity in XLA pa-
tients. In this regard, Btk has been shown to play an im-
portant role in signaling downstream of the LPS receptor,
TLR4. A number of studies have independently shown
that Btk is phosphorylated and thus activated following
acute LPS stimulation of cells [9-11]. Btk activation in
turn positively regulates the production of pro-
inflammatory cytokines such as TNF-α, IL-1β and IL-6. Re-
garding the molecular mechanism behind these effects,
Btk has been demonstrated to interact with the TIR do-
mains of TLR2, 4, 6, and 9, in addition to key signaling
molecules such as MyD88, Mal, and IRAK-1 [9], leading to
enhanced transactivation of the p65 subunit of NFκB (via
serine 536 phosphorylation) [10,13,14]. Btk in addition
has been shown to stabilize TNF-α mRNA via a p38-
dependent pathway in both X-linked immunodeficiency
(Xid) mice and in XLA patients, indicating additional roles
for Btk in regulating cytokine production in cells [10,15].
However the role for Btk in TLR4 signaling remains
somewhat unclear, with evidence indicating that Btk pos-
itively regulates the production of the immuno-
suppressive cytokine IL-10 in murine macrophages, and a
concomitant reduction IL-6 production [11]. In murine
bone marrow derived mast cells the absence of Btk has
been shown to result in similar or marginally enhanced
levels of TNF-α, IL-6, p38 kinase activity and H2O2 pro-
duction when compared with wild type cells following
TLR2 or TLR4 treatment [12]. In addition, Btk is known
to phosphorylate the adaptor protein Mal following TLR2
and TLR4 stimulation, which has been suggested to act
as a negative feedback mechanism on the TLR-4 pathway,
with phosphorylated Mal being targeted for SOCS1-
mediated polyubiquitination and subsequent degradation
[16]. These findings are potentially consistent with a
role for Btk in turning-off and limiting TLR4 responses,
and it is conceivable that Btk is having a dual role in reg-
ulating LPS responses, positively regulating acute re-
sponses whereas acting as a negative regulator at later
time points thus enabling or facilitating LPS tolerance.
Studies using immune cells from XLA patients have also
been conflicting. Specifically, whilst one study suggests
that Btk is not required for LPS induced MAPK activation
and inflammatory cytokine production in human monocytes
following LPS stimulation [17], a number of separate studies
demonstrate defects in both phagocytosis and inflammatory
cytokine production following TLR4 stimulation in mono-
cytes isolated from XLA patients, in keeping with a positive
role for Btk downstream of TLR4 [10,15,18].
Whilst studies in cells derived from XLA patients have
been controversial the increased incidence of mycoplasma
and enteroviral infections in XLA patients is suggestive of de-
fective TLR-mediated innate immune responses and possibly
IFN-γ production, in addition to a lack of humoral immunity
[19,20]. To date little is known regarding the contribution of
Btk to the regulation of cross-talk between antigen present-
ing cells and other cells of the innate immune system, for ex-
ample NK cells. Interestingly, a recent study examining DCs
from XLA patients found that stimulation with a range of
TLR ligands induced less maturation and reduced cytokine
production from XLA patient derived cells compared to
healthy control cells [21]. A role for Btk in regulating antigen
presentation and maturation of antigen presenting cells is
also indicated from the inability of MHC class II and CD40
to form a complex in the absence of Btk, resulting in im-
paired TLR-driven activation of APCs [22].
As such the current study sought to determine the precise
role of Btk in TLR4-mediated immediate early responses and
thus the role of Btk in shaping acute rather than chronic in-
nate immune responses. We found that following 4 h ad-
ministration of a lethal dose of LPS systemic levels of
TNF-α, IL-1β, IL-12, IL-18 and IFN-γ were reduced or ab-
sent in Btk-deficient mice compared with wild-type mice,
whereas IL-6 and IL-8 levels were unchanged. Importantly,
APCs from Btk-deficient mice failed to mature and induce
the production (both at the mRNA and protein level) of
the NK cell activating cytokine IL-12 and IL-18. This conse-
quently resulted in diminished activation of NK cells and an
almost complete absence of IFN-γ production in Btk-
deficient mice. Our findings suggest that in the absence
of Btk, the ability of APCs to interface with other innate
immune cells such as NK cells is lost, resulting in an almost
complete absence of systemic IFN-γ production.
2. Materials and methods
2.1. Reagents
LPS was purchased from Cayla Invivogen (Escherichia coli
0111:B4). L929 conditioned medium (L929 CM) was used as
a source of macrophage colony stimulating factor (M-CSF).
Briefly L929 cells (ATCC) were incubated in RPMI-1640 supple-
mented with 10% fetal calf serum, penicillin (100 U/ml),
streptomycin (100 μg/ml) for 5–7 days. Cell free supernatant
was then harvested from confluent monolayers, passed
through a 0.22 μm membrane filter and kept at −20 °C until
use. CHO FLT3L cells were a kind gift from Dr. Kate Fitzgerald
(UMASS Medical School, Worcester, MA) and were maintained
in DMEM Hams F12 containing 10% fetal calf serum, penicillin
(100 U/ml), streptomycin (100 μg/ml). Recombinant murine
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IFN-γwas purchased from ImmunoTools. Recombinant murine
IL-12 and IL-18 were purchased from Sigma.
2.2. Mice
Btk deficient mice were housed and bred in the Biomedical
Research Facility at Queens University Belfast and at the
Royal College of Surgeons in Ireland under specific
pathogen-free conditions and used at 6–10 weeks. The animals
were used in accordance with ethical approval and license
conditions.
2.3. Intraperitoneal (i.p) LPS injection
Age-matched (6 to 10 weeks) wild type (WT) C57BL/6 mice
(Harlan Laboratories) and Btk-deficient mice were adminis-
tered an intraperitoneal injection of 8 mg/kg LPS dissolved
in sterile saline solution. Control mice were given an intra-
peritoneal injection of the equivalent volume of saline.
Blood was obtained via tail vein bleed at various times
prior to LPS injection and during treatment period to moni-
tor serum cytokine levels. Following LPS treatment mice
were culled by CO2 asphyxiation.
2.4. Preparation of BMDMs and BMDCs
Bone marrow cells were flushed from hind legs of C57BL/6
mice or Btk-deficient mice and bone marrow derived macro-
phages (BMDMs) were derived by differentiating bone mar-
row cells in DMEM (Dulbecco's modified Eagle's medium)
supplemented with 10% L929 conditioned medium, 10% fetal
calf serum, penicillin (100 U/ml), streptomycin (100 μg/ml)
and 1% L-glutamine for 7 days. Bone marrow derived dendritic
cells (BMDCs) were derived by differentiating bone marrow
cells in RPMI containing 10% fetal calf serum, penicillin
(100 U/ml), streptomycin (100 μg/ml) and 1% L-glutamine,
supplemented with 10% FLT3L supernatant for 7 days. Purity
of cell populations was determined by flow cytometry.
2.5. Primary mouse splenocyte preparation and NK
cell purification
Spleens were harvested from C57BL/6 or Btk-deficient mice,
and splenocytes were obtained bymechanical cell dissociation
of the spleens using a 70-μm cell strainer (BD Falcon, Fisher,
Pittsburgh, PA). Red blood cells were lysed by treatment of
the cell suspension with red blood cell lysis buffer (RBC
lysis). Natural killer (NK) cells were purified from mouse sple-
nocytes by negative selection using NK cell enrichment kit
(Miltenyi). Purity of cell populations was determined by flow
cytometry. Sample purities were approximately 90%
CD3−DX5+ following negative selection.
2.6. Cytokine multiplex assay
Levels of mouse cytokines in serum and supernatant samples
were simultaneouslymeasured using amultiplex 7-spot electro-
chemiluminescence assay (Meso Scale Discovery, Gaithersburg,
MD) and read by an Imager 2400 plate reader (Meso Scale
Discovery, Gaithersburg, MD). The cytokines analyzed in-
cluded TNF-α, IL-1β, IL-6, IL-8, IL-12p70, IL-10, and IFN-γ.
2.7. ELISA
The IL-18 ELISA kit components were purchased from R&D
Systems and used a rat anti-mouse IL-18 mAb (74) as the cap-
ture antibody, a biotin labeled rat anti-mouse IL-18 mono-
clonal antibody (93-10C) as the detection antibody, and
recombinant mouse IL-18 as a standard. IFN-γ ELISA (R&D
Systems) was performed according to manufacturer's in-
structions. TMB (3, 3, 5, 5-tetramethylbenzidine) HRP sub-
strate solution was used for colorimetric detection (Sigma).
2.8. Realtime PCR
Total RNA was extracted from cell cultures using an RNeasy
kit (Qiagen) and reverse transcribed to cDNA using Omnis-
cript reverse transcriptase (Qiagen) according to manufac-
turer's recommendations. Quantitative realtime PCR was
performed using SYBR Green Taq ReadyMix™ (Sigma) and
the data was normalized to a Gapdh reference. The primer
pairs for analysis are listed in Table 1. Realtime PCR data
was analyzed using the 2−ΔΔCt method [23].
2.9. Flow cytometric analysis
BMDMs, BMDCs and splenocytes were collected as detailed
above from WT or Btk-deficient mice and either left unsti-
mulated or stimulated for 24 h with 100 ng/ml LPS. Cells
were stained for F4/80, CD11b, CD11c, CD86, IA/IE,
(MHCII), CD107a, CD69 and DX5 using specific antibodies
(BD Biosciences) and analyzed by flow cytometry using a
FACSCantoII flow cytometer (BD Biosciences). Intracellular
levels of IFN-γ were determined in splenocytes following
24 h treatment with 100 ng/ml LPS. For intracellular stain-
ing splenocytes were surface stained followed by fixing
and permeabilizing using a Fix & Perm cell perme-
abilization Kit (Invitrogen) according to manufacturer's in-
structions and staining with a FITC conjugated anti-IFN-γ
antibody (eBioscience). Quadrants in dot plot graphs and
Table 1 Primer pairs for gene induction analysis.
Gene Forward Reverse
IL-18 AAAGTGCCAGTGAACCC TTTGATGTAAGTTAGTGAGAGTGA
IL10 GGTTGCCAAGCCTTATCGGA ACCTGCTCCACTGCCTTGCT
IL12p40 GGAAGCACGGCAGCAGAATA AACTTGAGGGAGAAGTAGGAATGG
GAPDH CATCAAGAAGGTGGTGAAGC CCTGTTGCTGTAGCTGTATT
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histograms were defined using fluorescently conjugated
isotype controls.
2.10. NK cell stimulation with BMDCs
NK cells (1×105) were cultured with BMDCs (1×105) in 96-well
flat bottomed plates in RPMI. LPS (100 ng/ml) was added and
the cells cultured for 24 h. The level of IFN-γ in the culture
supernatants wasmeasured by ELISA (R&D Systems).Where in-
dicated, co-culture experiments were performed in the pres-
ence of IL-12 (10 ng/ml) or IL-18 (10 ng/ml).
2.11. Statistical analyses
Two-tailed Students t tests were used to evaluate changes in
cytokine production and gene expression. Data were deemed
to be significantly different at P values less than 0.05.
3. Results
3.1. Btk enhances proinflammatory cytokine
production following LPS administration
Although a role for Btk as a regulator of TLR4 responses in
myeloid cells has been previously demonstrated there has
been a certain degree of controversy within this field to
date. For example, whilst we and others have shown that
Btk is critically involved in NFκB activation and specifically
p65 phosphorylation downstream of multiple TLRs including
TLR4, TLR7 and TLR9 [13,14], other groups have reported
that Btk is not essential for TLR4 driven inflammatory cyto-
kine production [17]. To definitively characterize the role
of BTK in TLR4-mediated immune responses, we challenged
C57BL/6 (WT) or Btk-deficient mice with a lethal dose of
the TLR4 ligand, LPS (8 mg/kg). Four hours post LPS chal-
lenge, systemic levels of inflammatory cytokines (IL-1β, IL-
Figure 1 Proinflammatory cytokine production in mice lacking Btk. Wild-type (WT) and Btk-deficient mice were injected i.p. with
8 mg/kg LPS or saline as control and 4 h later serum was collected by tail-vein bleed and assayed for (A) TNF-α, (B) IL-6, (C) IL-8,
(D) IL-1β, (E) IL-12p40, (F) IFN-γ, (H) IL-10 using Meso Scale Discovery multiplex ELISA. (G) IL-18 was assayed by standard sandwich
ELISA (R&D). (n=4 for each treatment group). Bars represent mean±SD. *pb0.05.
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6, IL-8, IL-10, IL-12p40, IL-18, TNF-α and IFN-γ) were mea-
sured (Fig. 1). Consistent with a role for Btk as a positive reg-
ulator of TLR4 responses, LPS treatment of Btk-deficient
mice resulted in reduced production of the pro-
inflammatory cytokines TNF-α, and IL-1β compared to WT
controls (Figs. 1A and B), whereas IL-6 and IL-8 levels were
unaffected between the two groups (Figs. 1C and D). Strik-
ingly, the ability of Btk-deficient mice to produce IL-12, IL-
18, and IFN-γ in response to LPS was also severely impaired
indicating that the mechanisms that control and regulate
IFN-γ production may be defective in the Btk deficient
mice (Figs. 1E–G). Interestingly we observed enhanced pro-
duction of the key immunomodulatory cytokine IL-10 in
Btk-deficient mice in response to LPS (Fig. 1H), suggesting
that a skewing of cytokine responses from immunostimula-
tory to immunosuppressive occurs in response to LPS in the
absence of Btk.
As myeloid cells are a key source of IL-12 and IL-18 and
promote the production of IFN-γ from natural killer (NK)
cells, we next sought to investigate the ability of APCs
Figure 2 Impaired TLR4 responses in antigen presenting cells in the absence of Btk. (A-B) BMDMs (A) and BMDCs (B) were generated
from WT and Btk-deficient mice and treated with 100 ng/ml LPS for 24 h. Activation was determined by examining expression of CD86
and MHC Class II by flow cytometry (FACSCanto; BD Biosciences, San Diego, CA) using an APC-conjugated and a FITC-conjugated
antibody respectively. (C–H) WT or Btk-deficient BMDMs (C–E) or BMDCs (F–H) mice were treated with LPS (100 ng/ml) over the
indicated time course. Induction of IL-12p40, IL-18 and IL-10 mRNA induction relative to baseline levels was measured over the indi-
cated time course by real-time PCR following normalization with β-actin mRNA expression. In all cases, results shown are mean±SD
from three independent experiments. (I–K) WT or Btk-deficient BMDMs were treated with LPS (100 ng/ml) for 24 h. Supernatants
were harvested and assayed for (I) IL-12p70 and (K) IL-10 using Meso Scale Discovery multiplex ELISA. (J) IL-18 was assayed by stan-
dard sandwich ELISA (R&D).
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derived from Btk-deficient mice to respond to LPS and to
drive IL-12 and IL-18 production (Fig. 2). Bone marrow de-
rived macrophages (BMDM) and bone marrow derived den-
dritic cells (BMDC) derived from WT or Btk deficient mice
were stimulated ex vivo with LPS (100 ng/ml) and the ex-
pression of activatory and co-stimulatory surface antigens
was determined by flow cytometry (Figs. 2A–B). The ab-
sence of Btk resulted in impaired LPS mediated induction
of the co-stimulatory molecule CD86 (37% v 53%) and re-
duced expression of MHC class II (49% v 74%) when compared
to similarly treated WT BMDMs (Fig. 2A). Similarly we ob-
served that BMDCs derived from Btk-deficient mice had re-
duced expression of CD86 (11% v 28.1%) and MHC class II
(50.3% v 76.8%) following LPS exposure when compared to
BMDCs derived from WT mice (Fig. 2B), indicating a global
defect in APCs to become activated efficiently in the ab-
sence of Btk following TLR4 stimulation.
Having established impaired activation of Btk derived
APC populations we next determined the ability of BMDMs
and BMDCs to drive IL-12, IL-18 and IL-10 gene expression
by real-time PCR (Figs. 2C–H). In all cases WT BMDMs
and WT BMDCs (Figs. 2C–D and F–G, black bars) responded
more efficiently to LPS by inducing significant increases in
IL-12 and IL-18 gene expression. In contrast Btk-deficient
BMDMs and BMDCs displayed virtually no increase in IL-12
or IL-18 mRNA (Figs. 2C–D and F–G, gray bars). Consistent
with ELISA data from in vivo studies, induction of IL-10
mRNA was shown to be significantly increased in Btk-
deficient macrophages and dendritic cells compared to
WT cells (Figs. 2E and H, respectively), in keeping with
our profile of an immunosuppressive cytokine milieu in
the absence of Btk. This altered profile of gene induction
observed in the absence of Btk was mirrored by impaired
production of IL-12 and IL-18 protein and enhanced IL-10
protein production as measured by ELISA for TLR 4 treated
BMDMs (Figs. 2I–K), indicating that the loss of IL-12 and IL-
18 at the protein level is as a result of decrease in mRNA
synthesis, rather than an inability to process and secrete
the relevant cytokines
3.2. Btk-deficient APCs are unable to drive NK cell
activation and IFN-γ production
The reduced ability of Btk-deficient macrophages to drive IL-
12 and IL-18 production prompted us to investigate what ef-
fect loss of Btk would have on the ability of macrophages and
dendritic cells to drive IFN-γ production from Natural Killer
(NK) cells, a key early source of IFN-γ. Splenocytes were iso-
lated from WT and Btk-deficient mice and were left
untreated or stimulated with LPS (100 ng/ml) ex vivo for
24 h and the relative expression of the early activation
marker CD69 was determined on NK cells by flow cytometry.
Whereas LPS induced a 2 fold increase in CD69 expression on
WT NK cells in a mixed culture experiment expression of
CD69 was reduced on LPS treated NK cells from Btk-
deficient mice in comparison to WT NK cells (Fig. 3A). In ad-
dition we also observed that production of IFN-γ was re-
duced in NK cells from Btk-deficient mice compared to WT
controls (Fig. 3B). These results indicate either a possible
defect in NK cell responses upon LPS exposure or that signals
that drive NK cell activation by macrophages and dendritic
cells (IL-12/IL-18 and interaction with APCs) are impaired
in Btk-deficient mice.
To investigate these responses in greater detail, we puri-
fied NK cells (DX5+ cells) by negative selection (Miltenyi)
from splenocytes and co-cultured them with bone marrow
derived dendritic cells (BMDCs) from either WT or Btk-
deficient mice and examined NK cell activity by examining
surface expression of CD107a, which is associated with NK
cell cytotoxic function [24] and by measuring IFN-γ produc-
tion. Co-culture of BMDCs derived from WT mice with puri-
fied WT NK cells in the presence of LPS resulted in a
fourfold increase in CD107a expression, indicating NK cells
were activated (Fig. 4A). In contrast, Btk-deficient BMDCs
failed to induce any significant increase in CD107a expres-
sion on NK cells derived from Btk-deficient mice (Fig. 4B).
Importantly we found that whilst WT DCs had the capacity
to activate Btk-deficient NK cells (Fig. 4C), leading to a com-
parable increase in CD107a expression observed in WT NK
cells, Btk-deficient DCs failed to induce any increase in
CD107a expression on WT NK cells (Fig. 4D). Similarly, WT
DCs were capable of inducing IFN-γ production from WT
and Btk-deficient NK cells with equal efficiency following
LPS treatment (Fig. 4E), whilst Btk-deficient DCs failed to in-
duce NK cell activation and hence IFN-γ production from ei-
ther WT or Btk-deficient NK cells (Fig. 4E). Our results
Figure 3 Absence of Btk results in impaired activation of NK
cells. (A) Splenocytes were harvested from WT or Btk-deficient
mice and were left untreated or were stimulated ex vivo with
LPS (100 ng/ml) for 24 h. Expression of CD69 on NK cells was de-
termined by co-staining with DX5. (B) Splenocytes were treated
with LPS (100 ng/ml) for 24 h. Intracellular levels of IFN-γ were
determined in NK cells by co-staining with DX5. Quadrants in dot
plot graphs and histograms were defined using fluorescently
conjugated isotype controls.
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strongly point to the defect in IFN-γ production in response
to LPS being due to a failure of Btk-deficient APCs to acti-
vate NK cells, rather than any inherent defect in the Btk-
deficient NK cells to respond to activatory signals.
In keeping with the important role for DC derived IL-12
and IL-18 in the activation of NK cells, inclusion of the cyto-
kines IL-12 or IL-18 alone or in combination rescued the abil-
ity of Btk-deficient DCs to activate Btk-deficient NKs
following LPS treatment (Fig. 4E). These results support an
important role for Btk in regulating APC function downstream
of TLR4 and indicate that the NK cell defect observed in the
absence of Btk is a result of impaired APC activation which
can be restored with the exogenous addition of IL-12 or IL-
18 alone or in combination. These results havemajor implica-
tions for our understanding of enteroviral susceptibility in
the XLA patients and opens possible novel avenues for thera-
peutic intervention.
4. Discussion
Our current findings demonstrate that Btk is critically re-
quired by macrophages and dendritic cells to enable them
to respond appropriately to TLR4 and induce expression of
cytokines and cell surface receptors that contribute to NK
cell activation. Our novel finding that TLR4-induced IL-12
and IL-18 production is completely defective in the absence
of Btk and results in complete lack of NK cell activation and
hence IFN-γ production, has important implications for our
understanding of the role of Btk in anti-viral and anti-
Figure 4 TLR4 mediated DC:NK cell crosstalk is impaired in the absence of Btk. (A–D) NK cells isolated from WT or Btk-deficient
splenocytes were co-cultured with corresponding BMDCs (A–B) or with BMDCs from counterparts (C–D) and CD107a expression was
determined by flow cytometry. Quadrants in dot plot graphs and histograms were defined using fluorescently conjugated isotype con-
trols. (E) 1×105 NK cells derived from WT or Btk-deficient mice were co-cultured with 1×105 BMDCs derived from WT or Btk-deficient
mice as indicated and left untreated or were treated with LPS (100 ng/ml). Where indicated co-culture experiments were performed
in the presence of IL-12 (10 ng/ml) or IL-18 (10 ng/ml) alone or in combination. Supernatants were collected 24 h post-stimulation to
determine IFN-γ production by ELISA. Results are expressed as mean±SD for three independent experiments. *pb0.05.
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tumor responses. Critically, although TLR-stimulated APCs
are unable to induce activation of NK cells in the absence
of Btk, the ability of NK cells to induce IFN-γ is restored
via exogenous addition of IL-12 and IL-18 in the presence of
Btk-deficient APCs, demonstrating that Btk-deficiency does
not impair NK cell responses but that the defect lies at the
level of APCs. This finding has important implications as
IFN-γ is a key anti-viral cytokine which plays a central role
in mediating innate and adaptive immune responses to
pathogen.
Evidence from both in vitro and in vivo studies has clearly
implicated a role for Btk downstream of TLRs and in particu-
lar downstream of the LPS receptor, TLR4. However, analy-
sis of the role of Btk in regulating systemic responses to
acute LPS administration is lacking. The results presented
herein suggest that Btk is required in order to drive optimal
cytokine responses to administration of the TLR4 ligand
LPS. In keeping with previous studies, systemic levels of
the pro-inflammatory cytokines TNF-α and IL-1β are signifi-
cantly reduced compared with responses induced in wild-
type (WT) mice, whereas IL-6 levels are unchanged
[9,10,13-15]. Our findings also show that IL-8 levels are
unchanged in response to LPS administration, supporting
previous studies indicating that Btk is not required for induc-
tion of IL-8 downstream of TLR4 [15]. In light of the known
role for Btk in regulating phosphorylation of the p65 subunit
of the proinflammatory transcription factor NFκB down-
stream of TLR4 and TLR7 these results support previous find-
ings suggesting Btk acts as a positive regulator of the early
phase of TLR-driven cytokine responses [13,14]. Additionally
we observe a significant increase in the production of the
immunosuppressive cytokine IL-10 in Btk-deficient mice fol-
lowing ip LPS injection. Increased IL-10 production together
with a significant reduction in IFN-γ production suggests that
loss of Btk may result in altered Th1/Th2 balance although
further studies are required to test this hypothesis.
It is evident from the available data that Btk is necessary
for regulating the balance of pro-inflammatory and immuno-
modulatory cytokines depending on the stimulus and the cell
type involved. A significant body of evidence points to a crit-
ical role for Btk in driving inflammatory responses down-
stream of multiple TLRs. However, several studies show no
such dependence on Btk for initiating an inflammatory re-
sponse [17,25,26], indicating that the role of Btk in this re-
spect is complicated. In the present study, immediate early
levels of cytokine production in response to a lethal dose
of LPS have been assessed, whilst other studies reporting
that Btk negatively regulates pro-inflammatory cytokines
such as IL-6 [11], have administered a sub-lethal dose of
LPS and examined its effects on cytokine production at
later time points, potentially mimicking tolerance induc-
tion. The possibility therefore exists that Btk may have a
dual function in mediating TLR signals, functioning initially
as driver of inflammation whereas at later time points it
may play a role in limiting the effects of TLRs, acting as a
negative regulator. Interestingly studies by Kawkami et al.
suggest that Btk plays a key role in autologous IL-10 produc-
tion and subsequent STAT-3 activation which functions to
negatively regulate APC maturation and function [27]. Addi-
tionally a dual role hypothesis is further supported by studies
demonstrating that Btk phosphorylates the key TLR4 adaptor
Mal, resulting in SOCS1-mediated ubiquitination and degradation
of Mal and hence negative regulation of TLR4-dependent path-
ways [16].
Interestingly, evidence is mounting supporting a role for
Btk in regulating antigen presenting cell function. Recent
studies by Lui et al. have shown that Btk is required to
form a signaling complex with CD40 and intracellular MHC
Class II at the endosome in order to drive potent pro-
inflammatory cytokine and type I IFN production down-
stream of TLRs [22], suggesting that Btk plays a key role at
the interface between innate and adaptive immunity. Our
findings that not only is macrophage and DC activation sup-
pressed in Btk-deficient mice in response to LPS, but that
their ability to produce the cytokines IL-12, and IL-18 is im-
paired at both the mRNA and protein level would support
this hypothesis and suggests that the inability of Btk-
deficient APCs to drive activation of other key cells of the in-
nate immune response may underlie the striking inability of
Btk-deficient mice to produce IFN-γ in response to LPS ad-
ministration. Interestingly previous studies examining LPS
treated rheumatoid fibroblast-like synoviocytes (RA FLS)
have suggested that Btk may play a role in regulating IL-18
production [28]. These studies found that Btk expression
was not observed in RA FLS and attributed this to the induc-
tion of miR346 which was found to repress Btk expression in
these cells and thus result in impaired stability of IL-18
mRNA.
Clearance of mycobacterial and enteroviral infections re-
lies heavily on NK cell activation and consequent IFN-γ pro-
duction [29-31]. The essential role that DC-derived
cytokines, in particular IL-12, IL-15 and IL-18, play in the in-
duction of NK cell cytotoxicity and IFN-γ production is well
established [1,4,32,33]. Additionally optimal NK cell activa-
tion requires NK:DC cell contact in the form of DC expressed
NKp30 which promotes NK cell cytotoxic function [34]. Inter-
estingly this relationship has been shown to be reciprocal
with NK cells playing a role in DC maturation and subsequent
activation of naïve T cells via production of TNF-α and IFN-γ
[2,33]. Our study now helps explain the increased suscepti-
bility to recurrent enteroviral infections observed in XLA pa-
tients [19-21].
Given that NK cell activation and IFN-γ production is se-
verely impaired in Btk-deficient mice and that this defect
is not at the level of the NK cells themselves but instead re-
sides in an inability of Btk-deficient DCs to drive the activa-
tion of the NK cells, our work suggests that reduced NK cell
activity as a result of defective APC function in XLA patients
may underlie this enhanced susceptibility. The fact that ac-
tivity of NK cells derived from Btk-deficient mice could be
restored following co-culture of Btk-deficient NK cells with
activation competent WT BMDCs or Btk-deficient BMDCs sup-
plemented with exogenous IL-12 or IL-18 suggests that ther-
apies aimed at augmenting NK cell activation in XLA
patients, such as exogenous IL-12, IL-18 or indeed IFN-γ,
may be important in treatment of such infections. In keeping
with our findings, studies by Jyonouchi et al. have demon-
strated that XLA patients have similar levels of NK cell activ-
ity against herpes simplex virus infected fibroblasts as
healthy controls [26]. Importantly exogenous IL-12 has
been shown to provide protection from enteroviral infection
through increasing IFN-γ production from NK and NK T cells
[28], indicating that a similar mechanism may rescue the
IFN-γ defect in the Btk-deficient mice observed in this
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study. Interestingly, induction of IL-10 during coxsackie virus
infection is associated with delayed induction of innate and
adaptive responses [35]. Given that we observed enhanced
IL-10 production in APCs derived from Btk-deficient mice in
response to LPS administration, one might speculate that
the shift of balance towards an immunosuppressive environ-
ment in the absence of Btk may in part explain the enhanced
susceptibility to recurrent bacterial and enteroviral infec-
tions [20] observed in the XLA patients.
Overall our findings clearly demonstrate that Btk is func-
tioning at an important interface between innate immune
cells such that NK cell activation is impaired in the absence
of Btk, as a result of reduced APC derived IL-18 and IL-12.
These findings have important therapeutic implications, as
mechanisms that promote DC-NK cell crosstalk could poten-
tially reduce the incidence and severity of enteroviral infec-
tion in these individuals.
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